Ashe Morris in collaboration to co-develop glass-lined Coflux reactors
Two process manufacturing companies based in the UK and Germany have teamed up to develop batch reactors with improved performance.
Ashe Morris, a specialist in the development of process equipment for the chemical and pharmaceutical industries based in Runcorn, UK has signed a collaboration agreement with Robbins & Myers Process Solutions Group (Pfaudler) for the development Coflux glass lined batch reactors.
The product uses a variable geometry heating/cooling jacket, which offers faster and more stable temperature control, the ability to set the jacket height to suit the level in the vessel and improved energy efficiency. It also provides very sensitive process heat data - serving as a robust and versatile Process Analytical Technology (PAT) tool. Batch reactor users can also improve the economics of batch process such as chemical reactions and crystallisation through real time analytical data.
As part of the collaboration, Ashe Morris and Pfaudler, a sp
Two process manufacturing companies based in the UK and Germany have teamed up to develop batch reactors with improved performance.
Ashe Morris, a specialist in the development of process equipment for the chemical and pharmaceutical industries based in Runcorn, UK has signed a collaboration agreement with Robbins & Myers Process Solutions Group (Pfaudler) for the development Coflux glass lined batch reactors.
The product uses a variable geometry heating/cooling jacket, which offers faster and more stable temperature control, the ability to set the jacket height to suit the level in the vessel and improved energy efficiency. It also provides very sensitive process heat data - serving as a robust and versatile Process Analytical Technology (PAT) tool. Batch reactor users can also improve the economics of batch process such as chemical reactions and crystallisation through real time analytical data.
As part of the collaboration, Ashe Morris and Pfaudler, a specialist in glass-lined process equipment and manufacture, is inviting pharmaceutical and chemistry manufacturers to participate in trials and learn how Coflux can improve yield, quality and cycle time of their processes.
Robert Ashe of Ashe Morris, said: "We are extremely pleased that Pfaudler have agreed to be development partners for Coflux. Their experience and knowledge in the field of chemical reactors will make a major difference to development of this technology."
Andrew Wills, managing director of Robbins & Myers Process Solutions Group, said: "The Ashe Morris technology is potentially a major step forward in batch reactor technology and this co-operation agreement will be part of a strategic initiative by Pfaudler. By the conclusion of this project, we expect to prove to our customers that Coflux is not only practical but delivers major performance advantages for batch reactors."